We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+3.66%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.03B
AUM Growth
+$1.87B
Cap. Flow
+$1.68B
Cap. Flow %
18.63%
Top 10 Hldgs %
13.82%
Holding
1,787
New
329
Increased
1,367
Reduced
42
Closed
46

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$58.9M
2
MSFT icon
Microsoft
MSFT
+$45.4M
3
AMZN icon
Amazon
AMZN
+$30.9M
4
META icon
Meta Platforms (Facebook)
META
+$28.6M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$27M

Top Sells

Rank Stock Value
1
LLTC
Linear Technology Corp
LLTC
+$2M
2
MRGR icon
ProShares Merger ETF
MRGR
+$1.93M
3
AA icon
Alcoa
AA
+$1.78M
4
RALS
ProShares RAFI Long/Short
RALS
+$1.32M
5
WFM
Whole Foods Market Inc
WFM
+$1.24M

Sector Composition

Rank Sector Weight
1 Financials 15.42%
2 Healthcare 14.55%
3 Technology 12.09%
4 Consumer Staples 11.44%
5 Industrials 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGLS
1751
DELISTED
Regulus Therapeutics
RGLS
– –
-310
Closed -$123K
DCOY
1752
Decoy Therapeutics
DCOY
$2.98M
– –
0
– -$146K
TPST icon
1753
Tempest Therapeutics
TPST
$15.4M
– –
-9
Closed -$182K
ATYR
1754
aTyr Pharma
ATYR
$50M
– –
-1,068
Closed -$48K
TVRD
1755
Tvardi Therapeutics
TVRD
$30M
– –
-536
Closed -$161K
CMRX
1756
DELISTED
Chimerix, Inc.
CMRX
– –
-33,365
Closed -$185K
INFI
1757
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-36,117
Closed -$56K
CNCE
1758
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-15,648
Closed -$158K
AGTC
1759
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-12,630
Closed -$124K
SRRA
1760
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-478
Closed -$35K
DRNA
1761
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-13,089
Closed -$77K
CHMA
1762
DELISTED
Chiasma, Inc. Common Stock
CHMA
– –
-15,361
Closed -$45K
NEOS
1763
DELISTED
Neos Therapeutics, Inc
NEOS
– –
-11,490
Closed -$76K
TTPH
1764
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-1,337
Closed -$102K
ECYT
1765
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-30,401
Closed -$94K
EGLT
1766
DELISTED
Egalet Corporation
EGLT
– –
-18,030
Closed -$137K
ANTH
1767
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
– –
-3,749
Closed -$94K
CXRX
1768
DELISTED
Concordia International Corp. Common Stock
CXRX
– –
-32,176
Closed -$144K
CASC
1769
DELISTED
Cascadian Therapeutics, Inc.
CASC
– –
-14,178
Closed -$140K
SCLN
1770
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
– –
-37,435
Closed -$384K
TLN
1771
DELISTED
Talen Energy Corporation
TLN
– –
-15,015
Closed -$208K
IM
1772
DELISTED
Ingram Micro
IM
– –
-15,182
Closed -$541K
COWN
1773
DELISTED
Cowen Inc. Class A Common Stock
COWN
– –
-2,522
Closed -$37K
AMSG
1774
DELISTED
Amsurg Corp
AMSG
– –
-5,136
Closed -$344K
PPS
1775
DELISTED
Post Properties
PPS
– –
-16,112
Closed -$1.06M
68 69 70
71
72

Similar funds

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

ProShare Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, ProShare Advisors held 1,787 positions worth $9.03B, up 26% from $7.16B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

ProShare Advisors deployed $1.68B of net new capital in Q4 2016, opening 329 new positions and adding to 1,367 existing holdings. Its largest new stake was Opko Health: 373,523 shares worth $3.47M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Linear Technology Corp, an estimated $2M trimmed.

  • ProShare Advisors's largest Q4 2016 buy was Opko Health: 373,523 shares worth $3.47M.
  • ProShare Advisors added most to Apple in Q4 2016, an estimated $58.9M increase.
  • ProShare Advisors's biggest Q4 2016 reduction was Linear Technology Corp, cutting an estimated $2M.
  • ProShare Advisors fully exited Post Properties in Q4 2016, selling an estimated $1.06M.
  • ProShare Advisors's ten largest holdings make up 14% of its $9.03B portfolio in Q4 2016.
  • ProShare Advisors opened 329 new positions and closed 46 in Q4 2016.
  • ProShare Advisors's portfolio value rose 26% quarter-over-quarter to $9.03B.

Based on ProShare Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.